Loading...
Role of CD20 Monoclonal Antibodies in Previously Untreated Chronic Lymphocytic Leukemia
Monoclonal antibodies (mAbs) directed against the CD20 antigen on B cells have dramatically altered the treatment landscape for patients with chronic lymphocytic leukemia (CLL). Rituximab, a chimeric mouse/human mAb, was the first antibody to be approved for treatment of indolent B cell lymphomas. A...
Saved in:
| Published in: | Clin Lymphoma Myeloma Leuk |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
2010
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4624201/ https://ncbi.nlm.nih.gov/pubmed/20529805 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3816/CLML.2010.s.004 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|